Webinaire

WHO PCV vaccination recommendations: 1p+1 dose schedules

Pneumococcal disease is a leading cause of death and serious illness in young children, especially in low- and middle-income countries. Since 2007, WHO has recommended the introduction of PCV into routine infant immunization programmes globally. As a result of PCV introduction, the incidence of invasive pneumococcal disease has dramatically decreased over time. PCV prevents severe diseases like meningitis, pneumonia, and sepsis, as well as milder conditions like otitis media.

WHO has recently released an updated PCV Position Paper to reflect new evidence from recent studies and real-world use, which will help countries in optimizing PCV product, schedule, and/or strategy to improve vaccine coverage, reduce costs, and ultimately save more children's lives, especially in resource-limited settings. The Position Paper is available here: https://iris.who.int/server/api/core/bitstreams/2cce44bc-af0b-4103-9048-54353f7d7ba1/content

This webinar presented and discussed over aspects related to the 2-dose schedule recommendation (1p+1) that will be useful to immunization related staff.

The presentation slides of this webinar session are available here

Date

2025-11-19

Type

Webinaire

Catégories

  • Gestion de programme

Maladies

  • Infection à pneumocoque

Organisations

  • Organisation Mondiale de la Santé (OMS)

TN-WEBINAR-2025

TitreAuteurAnnéeTypeLangue
Using digital technologies to enhance implementation of home- based records/ personal health records for maternal, newborn and child healthLaura Nic Lochlainn, Natschja Ratanaprayul, Hassan Sibomana, Pawan Kumar, Tomoya Yoshida, Annie Portela2025WebinarAnglais, Français
Launch of "Operational Guidance: Multisectoral zero-dose strategies to improve routine immunization and other child outcomes" and accompanying case study compendium Ibrahim Dadari, Desiree Stewart2025WebinarAnglais, Arabe, Français, Espagnol
Alternative methods for the validation of maternal and neonatal tetanus elimination (MNTE) in armed conflict and other access-constrained settingsNasir Yusuf2025WebinarAnglais, Français
Show me the data! Deep dive into understanding and optimizing vaccine wastage rates and resupply decisionsLaila Akhlaghi, Wendy Prosser2025WebinarAnglais
Ask Me Anything about EVM and cIPDan Brigden, Olamide Folorunso, Zainab Berry, Erida Nelaj2025WebinarAnglais
Dissemination for the targeted and selective strategies in measles and rubella vaccination campaigns: interim guidanceOniovo Efe-Aluta, Santosh Gurung2025WebinarAnglais, Français
Rabies elimination – the basicsBernadette Abela, Frederic Lohr, Zsofia Hesketh, Juan Pablo Arguello Yepez, Kerenza Vlastou, Lunsungu Ngulube, Simbarashe Mabaya2025WebinarAnglais, Français
Protection from birth: Expanding access to hepatitis B birth doseFunmi Lesi, Sidy Ndiaye, Simbarashe Mabaya, Louise Henaff, Muhammad Shahid Jamil, Stephanie Shendale2025WebinarAnglais, Français
Catch-Up Vaccination: Insights from 5 Big Catch-up Country Case StudiesDaniela Rodriguez, Ariel Higgins-Steele, Victoria Ngako, Chisom Obi-Jeff, Chinyere Okeke, Makki Ahmed, Stephen Mshana, Sheikh Al-Shoteri, Stephanie Shendale2025WebinarAnglais, Arabe, Français
Introduction to Post Market Monitoring of cold chain equipmentPaul Mallins, Edda Magnus, Matt Morio, Danya Arif Siddiqi2025WebinarAnglais
Reaching Zero-Dose Children: Insights from Six Implementation Research StudiesDaniela Rodriguez, Collins Buh, Dora Dadzie, Sylvestre Bemanana, Dziko Chatata, Lucia Vieira, Rutaba Syed, Jane Dzoole, Sylvester Maleghemi2025WebinarAnglais, Français
WHO PCV vaccination recommendations: 1p+1 dose schedulesAlejandro Ramirez Gonzalez, Johanna Fihman, Maya M.V.X. van den Ent, Nathalie Salagnac2025WebinarAnglais, Français

Ajouté par: Moderator

Ajouté le: 2025-11-20 14:35:14

Consultations: 499